A leaky heart valve can now be treated without open-heart surgery using catheter-based procedures that reach the valve through a blood vessel in your leg. These minimally invasive options were once reserved only for patients too sick for surgery, but they’ve expanded significantly in recent years. The right approach depends on which valve is leaking, how severe the leak is, and your overall surgical risk.
How Catheter-Based Valve Repair Works
Instead of opening your chest and stopping your heart, a cardiologist threads a thin, flexible tube (catheter) through a blood vessel, usually in the groin area near the top of your thigh. The catheter carries a small device up through the vessel and into the heart, where it’s positioned at the leaking valve using real-time imaging. The femoral artery or vein in the leg is the preferred entry point whenever possible. When that route isn’t available due to vessel size or disease, doctors can access the heart through an artery near the collarbone or directly through the aorta with a small incision.
The opening required is remarkably small. The sheaths used to guide the catheter range from about 6 to 8 millimeters in diameter. Compare that to the 8- to 10-inch incision needed for traditional open-heart surgery, and you can see why recovery is dramatically shorter.
Options for the Mitral Valve
The mitral valve, which sits between the left atrium and left ventricle, is the most common valve to develop a leak. The primary non-surgical fix is a procedure called transcatheter edge-to-edge repair, or TEER. A small clip is delivered by catheter and used to pinch the two leaflets of the mitral valve together at the point where they’re failing to close properly. This reduces the backward flow of blood without replacing the valve entirely.
The best candidates for this procedure have a leak originating from the middle segments of the valve leaflets, with enough leaflet tissue for the clip to grasp. Patients with severe calcium buildup around the valve, rheumatic heart disease, or a very small valve opening (under 3.5 square centimeters) are generally not good candidates. That said, newer clip technology allows doctors to grasp each leaflet independently, which has opened the door for people with more complex anatomy, including wider gaps between the leaflets than earlier devices could handle.
Options for the Aortic Valve
Transcatheter aortic valve replacement, commonly called TAVR, is one of the most established catheter-based heart procedures. A new valve, compressed onto a catheter, is guided into position inside the old valve and expanded. It immediately takes over the job of regulating blood flow.
There’s an important caveat for aortic leaks specifically. TAVR was designed primarily for aortic stenosis, where the valve is stiff and narrowed, often with calcium deposits that help anchor the new valve in place. A purely leaky aortic valve without narrowing or calcification poses an anchoring problem, since there’s less structure for the replacement valve to grip. For this reason, TAVR for pure aortic regurgitation is still considered off-label. Newer-generation devices have improved outcomes considerably, with device success rates around 81% compared to about 61% with older models. The rate of significant residual leaking dropped from nearly 19% to just over 4% with these newer devices. Still, if you have a leaky aortic valve without stenosis, your heart team will need to carefully evaluate whether a catheter-based approach is feasible for your specific anatomy.
Options for the Tricuspid Valve
The tricuspid valve, on the right side of the heart, was long considered the “forgotten valve” because surgical repair carried high risks and few alternatives existed. That changed recently. In early 2024, the FDA approved the first transcatheter tricuspid valve replacement system. In the clinical trial that led to approval, 99% of patients who received the device had their severe leaking reduced to moderate or less, compared to just 22% of patients treated with medication alone. Patients with the device were about five times more likely to report improved quality of life, fewer symptoms like shortness of breath and fatigue, and better exercise tolerance at six months.
The procedure does carry real risks. About 28% of patients in the trial experienced a major complication within 30 days, including heart-related death, need for a permanent pacemaker, or severe bleeding. These are the kinds of tradeoffs your cardiologist will weigh against the severity of your symptoms and how much the leak is affecting your heart function.
Who Qualifies for a Catheter-Based Procedure
Eligibility is determined largely by your surgical risk score. The most widely used tool is the STS (Society of Thoracic Surgeons) risk model, which estimates your chance of complications from traditional surgery based on age, other medical conditions, kidney function, and dozens of other factors. The risk categories break down roughly as follows:
- Low risk: STS score below 4%. Traditional surgery is typically recommended, though TAVR has been approved for low-risk aortic stenosis patients as well.
- Intermediate risk: STS score of 4% or higher. Catheter-based options become a strong alternative.
- High risk: STS score of 8% or higher. Catheter-based procedures are often preferred.
- Inoperable: STS score above 15%. Surgery is not an option, making catheter-based treatment the only interventional choice.
Your valve’s anatomy matters just as much as your risk score. Imaging studies, usually an echocardiogram and sometimes a CT scan, help determine whether the shape and condition of your valve will work with the available devices. Not every leaky valve can be fixed with a catheter-based approach, and a heart team of surgeons and interventional cardiologists will review your case together.
What Recovery Looks Like
Recovery from a catheter-based valve procedure is dramatically faster than open-heart surgery. Most people leave the hospital within one to two days. You can return to most normal activities within days, though you’ll need to avoid lifting heavy objects or strenuous physical activity for at least a week. Most people go back to work within two weeks and can drive again after about a month. Full recovery, meaning the access site in your leg is completely healed and you’ve regained your full energy, takes six to ten weeks.
For comparison, open-heart valve surgery typically requires five to seven days in the hospital and six to eight weeks before returning to work, with full recovery often taking three months or longer.
When Medication Is the Main Approach
Medications don’t fix a leaky valve. They manage the symptoms and reduce the strain on your heart while you and your doctor decide on timing for a procedure, or in cases where no procedure is appropriate.
For a leak caused by heart muscle dysfunction (called secondary or functional regurgitation), the treatment approach follows standard heart failure management. This typically means drugs that reduce fluid buildup, lower blood pressure, and ease the heart’s workload. These medications can meaningfully reduce symptoms like swelling, shortness of breath, and fatigue, even though the valve itself is still leaking.
For a leak caused by a structural problem with the valve itself (primary regurgitation), the evidence for medication is much weaker. Guidelines don’t recommend blood pressure medications or heart failure drugs for primary mitral regurgitation unless you also have high blood pressure or heart failure independently. In other words, if the valve itself is the problem and your symptoms are significant, medication is a bridge, not a destination. The fix is mechanical, either through a catheter or through surgery.
Mild valve leaks that aren’t causing symptoms or heart changes often don’t need any treatment at all. Regular monitoring with echocardiograms, typically every one to two years, tracks whether the leak is stable or worsening. Many people live for years or decades with a mild leak that never requires intervention.